Posts Tagged 'Bayer'

Federal Essure Lawsuit Continues in Philadelphia

judge allows essure lawsuit to continueA federal judge in Philadelphia has determined that an Essure lawsuit filed against pharmaceutical giant Bayer has enough merit to proceed. Bayer had previously moved for the case to be dismissed.

The judge sided with Bayer on most of its motion. The plaintiffs had originally brought 12 claims against the company and, using an FDA provision specific to devices granted premarket approval, Bayer argued that Essure was effectively protected from any sort ...

continue reading...

What’s Going on with Mirena Litigation?

mirena lawsuits continue to stack upIt’s been a little while since we’ve written about Mirena here on the Lopez McHugh blog. That doesn’t mean, however, that the problems with the device have subsided.

One of three hormonal IUDs available on the American contraception market, Mirena’s history of complications is long, and continues to grow. As it stands at the moment, thousands of lawsuits have been filed against against Bayer Healthcare for injuries suffered as a result of ...

continue reading...

Xarelto: Higher Risk Same Reward?

xarelto may be no more beneficial than warfarin and be more dangerousOver 1,200 Xarelto lawsuits are pending in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana. Xarelto plaintiffs allege that the anticoagulant drug’s manufacturers, including Bayer HealthCare Pharmaceuticals and Johnson & Johnson’s Janssen Pharmaceutical, did not provide patients and doctors with adequate warning about Xarelto’s severe bleeding risks.

Approved by the U.S. Food and Drug Administration (FDA) in 2011 ...

continue reading...

Xarelto Lawsuit Filed by Wisconsin Woman

xarelto lawsuit filed in wisconsinA Wisconsin woman has filed a Xarelto lawsuit against multiple pharmaceutical companies for damages allegedly resulting from the anticoagulant drug. The plaintiff states that the defendants, including Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals, did not adequately warn doctors and patients of the risk of uncontrollable bleeding that Xarelto poses. The Xarelto lawsuit further claims that the drug’s manufacturers failed to provide appropriate instructions on how to intervene should serious bleeding ...

continue reading...

New Look at Long-Term Essure Data Adds Fuel to Fire

The female contraceptive market is a crowded one. A variety of options exist, each one tailored to meet a woman’s specific needs or desires for her particular contraceptive method. Some are physical, some are chemical, and others use a combined approach. As a result, a conversation with a physician or gynecologist about contraception can run the gamut.

About 13 years ago, one of the methods that would have come up during such a conversation was Essure. Essure is a small coil ...

continue reading...

FDA Fast Tracks Boehringer’s Pradaxa Antidote

pradaxa bleeding antidote being fast tracked by FDAThe U.S. Food and Drug Administration (FDA) has given Boehringer Ingelheim’s antidote to its problematic anticoagulant drug Pradaxa a fast-track review, FiercePhrama reports. According to the company, this will make Pradaxa the first “next generation” anticoagulant to receive an FDA-approved antidote.

Last year, the German drug manufacturer Boehringer Ingelheim agreed to pay $650 million to settle roughly 4,000 Pradaxa lawsuits in state and federal courts. Plaintiffs in ...

continue reading...
Page 1 of 31 12345...»